Photo by nci from unsplash
The cervical cancer screening recommendation for transgender female‐to‐male (FTM) patients is the same as that for cisgender females. A lack of literature on testosterone‐induced changes in cervical cytology in these… Click to show full abstract
The cervical cancer screening recommendation for transgender female‐to‐male (FTM) patients is the same as that for cisgender females. A lack of literature on testosterone‐induced changes in cervical cytology in these patients may result in interpretation errors, especially without a proper clinical history. The aim of this study was to delineate the Papanicolaou (Pap) test findings in this patient population.
Keywords:
transgender;
cytomorphologic findings;
findings cervical;
female male;
cervical pap;
pap smears
Journal Title: Cancer Cytopathology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer Cytopathology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!